Report: Fighting The High Cost Rx Drugs

Top Twenty Pay-For-Delay Drugs

How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers
Released by: CALPIRG

Top Twenty Pay-for-Delay Drugs: How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers,” reveals that these drugs were subject to an industry practice called “pay for delay,” in which brand name pharmaceutical companies pay off generic drug manufacturers to keep lower cost equivalents off the market, forcing consumers to pay higher brand-name drug prices.

Join Our Call

Tell your representative to stand up for our democracy, and amplify the voices of small donors in our elections.

Support Us

Your donation supports CALPIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code